| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 05/02/2002 | WO2001018172A3 Fibroblast growth factor-like polypeptides |
| 05/02/2002 | WO2000075365A9 COMPOUNDS AND METHODS TO ENHANCE rAAV TRANSDUCTION |
| 05/02/2002 | US20020052475 Cytokines for use in the treatment of autoimmune disease, inflammation, arthritis and multiple sclerosis |
| 05/02/2002 | US20020052409 Compounds and methods for treating mitochondria-associated diseases |
| 05/02/2002 | US20020052386 Pyrimidine derivatives |
| 05/02/2002 | US20020052378 Novel compounds and compositions as protease inhibitors |
| 05/02/2002 | US20020052352 Treating a malignant tumor, like a melanoma, using plant-derived compounds |
| 05/02/2002 | US20020052349 p-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agents |
| 05/02/2002 | EP1202065A1 Net, a transcription factor of the TCF family, as regulator of angiogenic expression. |
| 05/02/2002 | EP1201241A2 Compositions containing capsaicin or capsaicin analogues and a local anesthetic |
| 05/02/2002 | EP1201240A2 Heterocyclic derivatives useful as pharmaceutical agents |
| 05/02/2002 | EP1200602A1 Dsp-11 dual-specificity map kinase phophatase |
| 05/02/2002 | EP1200596A2 Human synthetases |
| 05/02/2002 | EP1200595A2 Myxoma virus genes for immune modulation |
| 05/02/2002 | EP1200586A2 Human nervous system-associated proteins |
| 05/02/2002 | EP1200582A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 05/02/2002 | EP1200442A1 2,3-benzodiazepine derivatives |
| 05/02/2002 | EP1200440A1 Quinuclidine derivatives for treatment of neurological disorders |
| 05/02/2002 | EP1200422A2 Pyrazole compositions useful as inhibitors of erk |
| 05/02/2002 | EP1200419A1 Aminothiazole derivatives and their use as crf receptor ligands |
| 05/02/2002 | EP1200409A2 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 05/02/2002 | EP1200398A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors |
| 05/02/2002 | EP1200133A1 Manipulation of tissue or organ type using the notch pathway |
| 05/02/2002 | EP1200119A2 Method for down-regulating gdf-8 activity |
| 05/02/2002 | EP1200095A1 Medicament with a protective effect against oxidative-toxic substances, particularly against cardiotoxic substances |
| 05/02/2002 | EP1200086A2 Methods for treating or preventing pain and anxiety |
| 05/02/2002 | EP1200073A2 SELECTIVE iGluR 5? RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE |
| 05/02/2002 | EP0918758B1 Process for preparing 1-substituted 4-cyano-1,2,3-triazoles |
| 05/02/2002 | CA2689012A1 Method for the treatment of neurological and neuropsychological disorders |
| 05/02/2002 | CA2427085A1 Transmembrane proteins |
| 05/02/2002 | CA2426779A1 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors |
| 05/02/2002 | CA2425288A1 Pyrrolidine modulators of ccr5 chemokine receptor activity |
| 05/02/2002 | CA2425283A1 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/02/2002 | CA2424475A1 Method for the treatment of neurological and neuropsychological disorders |
| 05/01/2002 | CN1347325A Novel amide derivs. as growth hormone secretagogues |
| 05/01/2002 | CN1346655A Liquid medicine for treating traumatic injury |
| 05/01/2002 | CN1346647A Quick-acting antalgic plaster for detumescence and detoxication |
| 04/30/2002 | US6380244 Nutritional and therapeutic uses of 3-hydroxyalkanoate oligomers |
| 04/30/2002 | US6380208 Administering nicergoline, optionally in combination with a pharmaceutically acceptable carrier for therapy of pyramidal spasticity of neurological diseases involving an attack of the pyramidal pathway |
| 04/30/2002 | US6378526 Methods of ophthalmic administration |
| 04/30/2002 | CA2358678A1 Heterocyclic derivatives useful as pharmaceutical agents |
| 04/25/2002 | WO2002033099A2 Human kinases |
| 04/25/2002 | WO2002032961A2 Novel polypeptides and nucleic acids encoding same |
| 04/25/2002 | WO2002032901A2 Bridged piperazine derivatives |
| 04/25/2002 | WO2002032900A2 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 04/25/2002 | WO2002032880A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |
| 04/25/2002 | WO2002032879A1 Dihydropyrimidine derivatives as cysteine protease inhibitors |
| 04/25/2002 | WO2002032842A2 Compounds with high monoamine transporter affinity |
| 04/25/2002 | WO2002032447A2 Cell damage inhibitor |
| 04/25/2002 | WO2002032439A1 A herbal pharmaceutical composition and its process |
| 04/25/2002 | WO2002032438A1 Pharmaceutical composition treating gynecological blood stasis diseases, cardio and cerebral vascular diseases, respiratory diseases and the like |
| 04/25/2002 | WO2002032422A2 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | WO2001078754A3 Soft tissue and bone augmentation and bulking utilizing muscle-derived progenitor cells, compositions and treatments thereof |
| 04/25/2002 | WO2001070208A3 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate |
| 04/25/2002 | WO2001058891A3 Piperazine and piperidine derivatives for treatment or prevention of neuronal damage |
| 04/25/2002 | WO2001047533A3 INHIBITION OF GSK-3$g(b) |
| 04/25/2002 | US20020049239 Novel indole and benzothiazole derivatives |
| 04/25/2002 | US20020049220 Substituted azoles |
| 04/25/2002 | US20020049214 Aralkyl and aralkylidene heterocyclic lactams and imides as selective agonists and antagonists of serotonin 1 (5-HT1) recepor, used in treating hypertension and all forms of depression |
| 04/25/2002 | US20020049210 Heteroaryl amines as novel acetylcholinesterase inhibitors |
| 04/25/2002 | US20020049182 Administering to a mammal a composition containing pyrimidine nucleotide precursors in amounts sufficient to treat symptoms resulting from mitochondrial respiratory chain deficiencies. |
| 04/25/2002 | US20020049162 Methods for inhibiting smooth muscle cell proliferation |
| 04/25/2002 | US20020048271 Methods and composition for restoring conformational stability of a protein of the p53 family |
| 04/25/2002 | CA2426604A1 Compounds with high monoamine transporter affinity |
| 04/25/2002 | CA2426487A1 Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 04/25/2002 | CA2426381A1 Cell damage inhibitor |
| 04/25/2002 | CA2426271A1 Dihydropyrimidine derivatives as cysteine protease inhibitors |
| 04/25/2002 | CA2426097A1 New derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication |
| 04/25/2002 | CA2425963A1 Human kinases |
| 04/25/2002 | CA2423789A1 Bridged piperazine derivatives |
| 04/24/2002 | EP1198570A1 Monomeric protein of the tgf-beta family |
| 04/24/2002 | EP1198568A1 Compositions and methods for the treatment of immune related diseases |
| 04/24/2002 | EP1198453A2 N-(indolcarbonyl-)piperazin derivatives |
| 04/24/2002 | EP1198241A1 Novel proteins |
| 04/24/2002 | CN1346283A External coated chewing gum products |
| 04/24/2002 | CN1083436C Process for preparing 1-substoituted 4-cyano-1,2,3-triazoles |
| 04/23/2002 | US6376530 A n-methylaspartic acid antagonist; nervous system disorders, analgesics |
| 04/23/2002 | US6376519 1-(4-sulfamylaryl)-3-substituted-5-aryl-2-pyrazolines and inhibitors of cyclooxygenase-2 |
| 04/23/2002 | US6376508 Treatments for spinal muscular atrophy |
| 04/18/2002 | WO2002031138A1 Paramyxovirus vector for transferring foreign gene into skeletal muscle |
| 04/18/2002 | WO2002031134A2 Novel serine protease genes related to dppiv |
| 04/18/2002 | WO2002031115A2 Nucleic acid molecules and polypeptides for immune modulation |
| 04/18/2002 | WO2002030938A1 Benzhydryl derivatives |
| 04/18/2002 | WO2002030898A1 N-(4-aryloxypiperidin-1-ylalkyl) cinnamic amides as ccr33 receptor antagonists |
| 04/18/2002 | WO2002030888A2 Tricyclic compounds and uses thereof |
| 04/18/2002 | WO2002030881A1 Sulfonylguanidine |
| 04/18/2002 | WO2002030473A1 Targeted therapeutic agents |
| 04/18/2002 | WO2002030354A2 Uridine therapy for patients with elevated purine levels |
| 04/18/2002 | WO2002017914A3 Fused pyrrolocarbazoles against inflammation |
| 04/18/2002 | WO2002008272A3 High affinity soluble interleukin-18 receptor |
| 04/18/2002 | WO2002008217A3 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 04/18/2002 | WO2001082952A3 USE OF α-MSH AND EPO FOR PREVENTING OR TREATING ISCHEMIC CONDITIONS |
| 04/18/2002 | WO2001072777A3 Human transcription factors |
| 04/18/2002 | WO2001068570A3 Il-8 receptor antagonists |
| 04/18/2002 | WO2001068569A3 Il-8 receptor antagonists |
| 04/18/2002 | WO2001026644A3 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 04/18/2002 | WO2000068385A9 Novel nucleic acids and proteins with growth hormone activity |
| 04/18/2002 | WO2000066106A9 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 04/18/2002 | US20020045645 Lactone integrin antagonists |
| 04/18/2002 | US20020045644 2-phenylpyran-4-one derivatives |